메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
정진근 (강원대학교)
저널정보
(사)한국사법학회 비교사법 비교사법 제16권 제2호(통권 제45호)
발행연도
2009.6
수록면
609 - 639 (31page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
In the field of IP(Intellectual Property) licenses, the open source license may make some extraordinary problems related to anti-trust act. In U.S., Daniel Wallace sued IBM, Red Hat and Novell for “restraint of trade by way of a licensing scheme to fix the prices of computer software”. Wallace claimed that the GNU GPL and the Linux operating system were a conspiracy that resulted in the foreclosure of competition in the market for computer operating systems. Also, in the field of bio-technology, some open source biotechnology projects use the power of the patent system to ensure that the core technology of the project and any innovations remain openly available under the copyleft licenses.
In the above case, the court finds that Mr. Wallace has failed to allege an antitrust injury such that his claim under Section 1 of the Sherman Act may move forward, for that the open source system is consistent with patent policy. Also, many scholars explains that the open source group is not trying to restrict the supply of available products. On the other hands, one might argue that open source arrangements could be characterized as an attempt by the original open source group to prevent the development of a downstream product that would be available on different terms.
But, the GPL encourages, rather than discourages, free competition and the distribution of computer operating systems, the benefits of which directly pass to consumers. These benefits include lower prices, better access and more innovation. Thus, the effects of Linux and the open source biotechnology system should not be considered anticompetitive under the antitrust rule of reason, and therefore should not constitute patent misuse.

목차

Ⅰ. 머리말
Ⅱ. 공개라이선스의 공정거래법 관련 사례
Ⅲ. 공개라이선스의 공정거래법 관련 쟁점
Ⅳ. 맺음말
참고문헌
Abstract

참고문헌 (23)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2013-360-001271621